Patients with severe asthma report fatigue, sleep disturbances, physical inactivity, and reduced work productivity as some of ...
Patients with severe asthma required fewer steroid bursts with tezepelumab-ekko, according to a poster presented at the 2025 American Academy of Allergy, Asthma & Immunology/World Allergy Organization ...
Biologics are genetically engineered medications designed to target and block substances that cause inflammation. In recent years, they’ve proven effective at treating severe asthma. Asthma ...
Eosinophilic asthma is a more severe subtype of asthma. Treatment options include inhaled and oral corticosteroids, leukotriene modifiers, and biologics. Eosinophilic asthma is a subtype of asthma ...
10 小时
Verywell Health on MSNHow to Create an Allergic Asthma Action PlanAn action plan is essentially a set of instructions to help patients know how to manage allergic asthma. Learn which steps to ...
13 天
Verywell Health on MSNWhat Causes Asthma and What Triggers an AttackAsthma is caused by a combination of factors. People who develop asthma may have a genetic predisposition and react to ...
A new report ranks Dallas as one of the most challenging places to live with seasonal allergies. A North Texas doctor ...
A severe attack of asthma also known as “Status asthmaticus” is an asthma attack that doesn’t get better with standard treatments based on out-patient care. It makes it hard to breathe and is a ...
FDA aligned on plan to initiate parallel Phase 2 trials of rademikibart in patients with moderate-to-severe asthma or COPD experiencing an ...
Historically, RSV has been studied mainly in infants and older adults, but recent research shows that it also poses a significant threat to adults with asthma and COPD. However, research on the virus ...
People with severe asthma insured by BlueCross BlueShield of Illinois may soon face a new hurdle in accessing a treatment that providers say is critically important to keeping certain patients alive ...
The first-in class medicine for severe asthma co-developed by AstraZeneca and Amgen is poised for accelerated approval after the US Food and Drug Administration granted it a breakthrough designation.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果